• #581508
  • 934
  • Sanofi Pasteur #589-05

Menactra® Meningitis Vaccine Meningococcal (Groups A,C,Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine, Preservative Free 4 mcg / 0.5 mL Injection Single Dose Vial 0.5 mL

MENACTRA VACCINE, VL 4MCG/.05M49281058905

Features
  • Menactra is indicated for active immunization of individuals 2 through 55 years of age for the prevention of invasive meningococcal disease
  • Menactra vaccine is administered as a 0.5 mL dose by intramuscular injection
  • In children 9 through 23 months of age, Menactra is given as a 2-dose series three months apart
  • More …
  Log In to Order
or

Professionals Also Viewed


Product Specifications


McKesson #581508
Manufacturer #589-05
BrandMenactra®
ManufacturerSanofi Pasteur
Country of OriginUnited States
ApplicationMeningitis Vaccine
Container TypeSingle Dose Vial
Dosage FormInjection
Generic Drug Code99539
Generic Drug NameMeningococcal (Groups A,C,Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine, Preservative Free
NDC Number49281-0589-05
Product DatingMcKesson Acceptable Dating: we will ship >= 90 days
Storage RequirementsRequires Refrigeration
Strength4 mcg / 0.5 mL
TypeIntramuscular
UNSPSC Code51201610
Volume0.5 mL
Features
  • Menactra is indicated for active immunization of individuals 2 through 55 years of age for the prevention of invasive meningococcal disease
  • Menactra vaccine is administered as a 0.5 mL dose by intramuscular injection
  • In children 9 through 23 months of age, Menactra is given as a 2-dose series three months apart
  • Do not administer this product intravenously or subcutaneously
  • Requires refrigeration
More Information